Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CERE

Cerevel Therapeutics (CERE) Stock Price, News & Analysis

Cerevel Therapeutics logo

About Cerevel Therapeutics Stock (NASDAQ:CERE)

Advanced Chart

Key Stats

Today's Range
$44.96
$44.96
50-Day Range
$40.30
$44.96
52-Week Range
$19.59
$44.99
Volume
N/A
Average Volume
1.71 million shs
Market Capitalization
$8.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CERE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerevel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CERE Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

CERE Stock Analysis - Frequently Asked Questions

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) released its quarterly earnings results on Wednesday, November, 1st. The biotechnology company reported ($0.61) earnings per share for the quarter, topping the consensus estimate of ($0.63) by $0.02.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cerevel Therapeutics investors own include NVIDIA (NVDA), Medtronic (MDT), Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), First Solar (FSLR) and Datadog (DDOG).

Company Calendar

Last Earnings
11/01/2023
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Coal & Consumable Fuels
Current Symbol
NASDAQ:CERE
Fax
N/A
Employees
300
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$432.84 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$3.71 per share
Price / Book
12.12

Miscellaneous

Free Float
172,903,000
Market Cap
$8.19 billion
Optionable
Optionable
Beta
1.40

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:CERE) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners